Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on March 26, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent for RNA Oligos Biological Reagents

Closed
NOI-NIAID-25-2258380Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
Federal
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Solicitation # 36C26027Q0058
The Department of Veterans Affairs, through Network Contracting Office 20, is seeking a comprehensive histology staining workflow system for the Puget Sound Health Care System in Seattle, Washington. The required system must include two immunohistochemistry and two in-situ hybridization immunostainers, two special stainers, and an integrated specimen tracking system to ensure patient safety, maintain a chain of custody, and monitor productivity. The workflow components must be fully automated, communicate with one another, and maintain compatibility with Data Innovations middleware as well as VISTA, Cerner, and any future electronic health record systems acquired by the VA. The contract follows a Cost Per Reportable Result pricing model and spans a base year from February 1, 2027, to January 31, 2028, with four subsequent one-year option periods extending through January 31, 2032. Technical requirements specify that the immunostainers must perform 100% of tests listed in the provided specifications and support simultaneous IHC, ISH, and Direct Immunofluorescence staining. Equipment must support Code 39 and Code 128 barcodes, include a safe hazardous waste removal system, and be provided with an uninterruptible power supply capable of supporting a 15-minute controlled shutdown. The contractor is responsible for the delivery, installation, and removal of equipment at no additional charge and must guarantee a minimum equipment uptime of 98%. Performance and method validation must adhere to CLSI guidelines and College of American Pathologists standards. Additionally, the contractor must comply with strict federal and VA information security directives, including those regarding data confidentiality and media sanitization. Emergency supply orders must be fulfilled within 24 hours of a verbal request, providing enough consumables for one week of normal operation.
260-NETWORK Contract Office 20 (36C260)

POSTED

1 day ago

DEADLINE

in 24 days
NAICS: 325413
New
Federal
6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Solicitation # 36C26227Q0046
The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.
262-NETWORK Contract Office 22 (36C262)

POSTED

3 days ago

DEADLINE

in 13 days

General Info

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

SBA

Documents

1

NOI-NIAID-25-2258380 - Notice of Intent for RNA Oligos

PDF, Low prioritypresolicitation
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
PRE-SOLICITATION NOTICE NOI-NIAID-25-2258380 NAICS - 325413 This is a Notice of Intent, NOT a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Integrated DNA Technologies Inc. for: - A-tag TSO primer 1 umole RNA Oligo 1 0.3 nmol 9-11, QTY 25 - Shipping and handling costs Delivery Location: Bethesda, MD 20892 The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable consumables may submit a capability statement. All required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov by April 4, 2025 1:00 pm. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS